Actos Whistleblower Lawsuit Questions Avandia Researcher’s Financial Ties to Takeda - Newsinferno.com

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland ...

Can Social Networks Cure Disease? Part I - Huffington Post

We ate ourselves into this problem, and we have to eat ourselves out of it. High cholesterol is not a statin deficiency, and diabetes is not an Avandia deficiency. It is not doing the same things better. What we are doing is not really working.

Diabetes: Pioglitazone and Rosiglitazone may be related to fracture risk - Xagena Medical News

Two drugs in this category, Pioglitazone ( Actos ) and Rosiglitazone, ( Avandia ) account for 21 percent of oral diabetes medications prescribed in the United States and 5 percent of those in Europe. Recent studies have suggested that these therapies may ...

Two-Drug Therapy Helped Kids With Type 2 Diabetes - YAHOO!

SUNDAY, April 29 (HealthDay News) -- Children with type 2 diabetes may achieve better blood sugar control with a combination of two drugs, metformin and Avandia, than with metformin alone, a new study suggests. However, Avandia (rosiglitazone) was recently ...

Teens with diabetes have trouble managing it, study says - Los Angeles Times

All had their blood sugar normalized with metformin, then received one of three treatments to try to maintain that control: metformin alone, metformin plus diet and exercise counseling, or metformin plus a second drug, Avandia. After nearly four ...

FDA Needs Post-Market Drug Plan, Institute Says - NationalJournal.com

One piece advice from the committee of experts: start these so-called post-market studies sooner. A good example is the diabetes drug Avandia, which raised cholesterol in some patients. “There was a hint in the early data about Avandia that it ...

Clara Barton Founded The American Red Cross - digtriad.com

The Food and Drug Administration issued a safety alert for the diabetes drug Avandia, marketed by GlaxoSmithKline, which disputed a report saying it was linked to a greater risk of heart attack. One year ago: The apocalypse did not arrive, despite the ...

This Day in History - San Mateo Daily Journal

The Food and Drug Administration issued a safety alert for the diabetes drug Avandia, marketed by GlaxoSmithKline, which disputed a report saying it was linked to a greater risk of heart attack. One year ago: The apocalypse did not arrive, despite the ...

Alzheimer’s Research Effort Seeks New Treatments by 2025 (Update 1) - Bloomberg

The approach didn’t improve other measures of mental function. GlaxoSmithKline Plc (GSK)’s Avandia, once the biggest selling diabetes drug, failed to benefit Alzheimer’s disease patients in a 2009 study. A 2008 study underscored the ...

Is There a New Indication for Actos in the Works? - Lawyers and Settlements

Actos, a drug designed to treat Type 2 diabetes, became the go-to drug for a time following the Avandia meltdown of a few years ago. Sales of Actos soared. But then came concerns over Actos side effects, including concern over Actos and bladder cancer.